Form D · Biotechnology
On Demand Therapeutics, Inc.
Tyngsboro, MA · CIK 0001470274
Offering snapshot reported Jun 17, 2011 · SEC filing
- Reported sold
- $2.62M Offering amount: $4.12M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2011 | Initial | $2,624,369 | No comparison | 1 | SEC filing |
| May 20, 2010 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Aug 13, 2009 | Initial | $830,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161457
Series A Preferred Stock and Convertible Promissory Notes and the underlying Common Stock issued upon conversion of such Preferred Stock and Notes.
Source: Form D, filed Jun 17, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charline Gauthier | Promoter |
| Ajit Gill | Director |
| Gil Kliman | Director |
| John Santini | Director |
| John T. Santini, Jr. | Executive |
| Gordon Saul | Executive, Promoter |
| Naveed Shams | Executive |
| Dave Weber | Director |
| David Weber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Industrial Way, Unit 1 A
Tyngsboro, MA, 01879
Tyngsboro, MA, 01879